European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) saw a large increase in short interest in September. As of September 30th, there was short interest totalling 17,700 shares, an increase of 2,112.5% from the September 15th total of 800 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading volume of 18,500 shares, the short-interest ratio is presently 1.0 days.

European Biotech Acquisition Stock Performance

NASDAQ EBAC remained flat at $9.92 during trading hours on Wednesday. 106 shares of the company traded hands, compared to its average volume of 30,028. European Biotech Acquisition has a one year low of $9.66 and a one year high of $10.50. The stock's 50-day moving average price is $9.89.

Institutional Trading of European Biotech Acquisition

A hedge fund recently raised its stake in European Biotech Acquisition stock. Cubist Systematic Strategies LLC raised its position in European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 136.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 60,555 shares of the company's stock after purchasing an additional 34,896 shares during the quarter. Cubist Systematic Strategies LLC's holdings in European Biotech Acquisition were worth $593,000 as of its most recent SEC filing.

European Biotech Acquisition Company Profile

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.

Read More

• Get a free copy of the StockNews.com research report on European Biotech Acquisition (EBAC)
• Institutional Investors Are Buying These Two Stocks
• Put Pep In Your Portfolio With Low-Beta Pepsico
• Is Take-Two Interactive Software Inc. a Q4 Winner?
• 3 Oil Stocks That Are Heating Back Up
• Why All the Buzz Around These 3 Stocks?

Receive News & Ratings for European Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for European Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.